ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,198.40
      -0.41%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.83
      0.35%
      Bitcoin
      62,602.50
      -0.39%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dare Bioscience Inc (DARE)

      7. Dare Bioscience Inc (DARE) News

      DARE

      Dare Bioscience (DARE)

      Dare Bioscience Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DARE
      DateTimeSourceHeadlineSymbolCompany
      10/11/20226:15AMTipRanksDaré Bioscience (DARE) Receives a Buy from H.C. WainwrightNASDAQ:DAREDare Bioscience Inc
      10/10/20228:00AMGlobeNewswire Inc.Daré Bioscience Announces IDE Approval for a Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal ContraceptiveNASDAQ:DAREDare Bioscience Inc
      09/15/20228:00AMGlobeNewswire Inc.Daré Bioscience to Participate in Two Upcoming ConferencesNASDAQ:DAREDare Bioscience Inc
      09/12/20226:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
      09/06/20228:00AMGlobeNewswire Inc.Daré Bioscience to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:DAREDare Bioscience Inc
      09/04/20228:15AMTipRanksDaré Bioscience (DARE) Gets a Buy from Dawson JamesNASDAQ:DAREDare Bioscience Inc
      08/29/20228:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
      08/29/20228:00AMGlobeNewswire Inc.Daré Bioscience Announces Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal DisorderNASDAQ:DAREDare Bioscience Inc
      08/24/20228:00AMGlobeNewswire Inc.Daré Bioscience, Inc. Announces Global Licensing Rights to the Novel Antimicrobial Glycerol Monolaurate for Vaginal HealthNASDAQ:DAREDare Bioscience Inc
      08/15/20226:36AMTipRanksDaré Bioscience (DARE) Gets a Buy from H.C. WainwrightNASDAQ:DAREDare Bioscience Inc
      08/14/20228:15AMTipRanksDawson James Reaffirms Their Buy Rating on Daré Bioscience (DARE)NASDAQ:DAREDare Bioscience Inc
      08/10/20221:40PMTipRanksAnalysts’ Top Healthcare Picks: Daré Bioscience (DARE), Allogene Therapeutics (ALLO)NASDAQ:DAREDare Bioscience Inc
      08/09/20228:35PMTipRanksDaré Bioscience (DARE) Receives a Buy from Brookline Capital MarketsNASDAQ:DAREDare Bioscience Inc
      08/09/20224:09PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DAREDare Bioscience Inc
      08/09/20228:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
      08/09/20228:00AMGlobeNewswire Inc.Daré Bioscience Reports Second Quarter 2022 Financial Results and Provides a Company UpdateNASDAQ:DAREDare Bioscience Inc
      08/02/20228:00AMGlobeNewswire Inc.Daré Bioscience to Host Second Quarter 2022 Financial Results and Company Update Conference Call and Webcast on August 9, 2022NASDAQ:DAREDare Bioscience Inc
      07/25/20229:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
      07/09/20228:15AMTipRanksDaré Bioscience (DARE) Gets a Buy Rating from Maxim GroupNASDAQ:DAREDare Bioscience Inc
      07/07/20225:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
      07/07/20228:00AMGlobeNewswire Inc.Daré Bioscience to Participate in Maxim Group Women’s Health PanelNASDAQ:DAREDare Bioscience Inc
      07/03/20228:20AMTipRanksDaré Bioscience (DARE) Gets a Buy Rating from Dawson JamesNASDAQ:DAREDare Bioscience Inc
      06/30/20228:00AMGlobeNewswire Inc.Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial VaginosisNASDAQ:DAREDare Bioscience Inc
      06/28/20224:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
      06/24/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAREDare Bioscience Inc
       Showing the most relevant articles for your search:NASDAQ:DARE